Nanomedicines – Ensuring Patient Safety through Regulatory Clarity

Authors

  • Michael P. Isles European Alliance for Access to Safe Medicines, Leigh-on-Sea, Essex, United Kingdom

DOI:

https://doi.org/10.33892/aph.2021.91.156-157

Keywords:

Nanomedicines, nanosimilars, hybrid application, centralised regulatory process

Published

2021-11-15

How to Cite

(1)
Isles, M. P. Nanomedicines – Ensuring Patient Safety through Regulatory Clarity. Acta Pharm Hung 2021, 91, 156-157.

Issue

Vol. 91 No. 3-4 (2021): Abstracts of DDRS 2021 Conference, November 15-17, 2021, Budapest, Hungary

Section

Short communication

Copyright (c) 2021 Acta Pharmaceutica Hungarica

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

APH is published as a diamond open-access journal under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons License